Spineway designs, produces, and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, etc. Net sales are distributed geographically as follows: France (24.4%), Europe (16.9%), Latin America (34.3%), Asia (18.2%) and the Middle East and Africa (6.2%).

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

10-15 Sales and Revenue Release - Q3 2026

More about the company

Market Cap	2.03M 2.29M 1.9M 1.73M 3.26M 220M 3.29M 22.94M 8.89M 112M 8.58M 8.4M 361M	P/E 2026 *	-1.62x	P/E 2027 *	-1.7x
Enterprise Value	4.63M 5.21M 4.32M 3.94M 7.43M 501M 7.5M 52.31M 20.27M 256M 19.57M 19.14M 822M	EV / Sales 2026 *	0.35x	EV / Sales 2027 *	0.65x
Free-Float	9.65%	Yield 2026 *	-	Yield 2027 *	-

07-30	Spineway SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-29	Spineway SA announced that it expects to receive ?1.5 million in funding	CI
04-30	Spineway SA Reports Unaudited Consolidated Revenue Results for the First Quarter of 2026	CI
02-17	Spineway SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-16	Zonebourse Company Earnings Calendar: February 17, 2026
01-13	Spineway Sa Announces Revenue Results for Second Half and Full Year 2025	CI
14/10/25	Spineway SA Reports Unaudited Consolidated Revenue Results for the Third Quarter and Nine Months of 2025	CI
30/07/25	Spineway SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
24/03/25	Spineway SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
19/12/24	Spineway Secures Approvals in Vietnam for Certain Product Lines	MT
18/12/24	Spineway Wins New Approvals in Vietnam and Registers Initial Orders	CI
15/10/24	Spineway SA Reports Unaudited consolidated Revenue Results for the Third Quarter and Nine Months of 2024	CI
22/09/24	Spineway SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI

07-30	Spineway : H1 2026 results	AQ
04-30	Spineway : First-quarter 2026 revenue	AQ
04-07	SPINEWAY : Minutes of the General Meeting of April 2, 2026	PU
02-17	Spineway : 2025 annual results	AQ
01-13	SPINEWAY : 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)	AQ

07-31	Bourse : Thales et Exail publient les bans, Amazon et Sony brillent
07-31	Les haussiers se rebellent
07-30	SPINEWAY : Résultats semestriels 2026
07-29	Agenda Zonebourse des résultats de sociétés : le 30 juillet 2026
04-30	SPINEWA : SPINEWAY

Manager	Title	Age	Since
Stéphane Le Roux CEO	Chief Executive Officer	66	27/09/2005
Erwan Martin DFI	Director of Finance/CFO	-	31/10/2024

Spineway SA Share Price Euronext Paris

Stocks

FR001400N2P2

Medical Equipment, Supplies & Distribution

Valuation: Spineway SA

Latest news: Spineway SA

Press Releases: Spineway SA

News in other languages: Spineway SA

Managers and Directors: Spineway SA

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Director	Title	Age	Since
Stéphane Le Roux CHM	Chairman	66	27/09/2005
Joseph Brigneaud BRD	Director/Board Member	48	12/10/2017
Bérangère Boggio BRD	Director/Board Member	46	25/04/2016

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEWAY SA	-.--%	-.--%	-	-	2.29M
ABBOTT LABORATORIES	+0.84%	-3.74%	-27.56%	+1.79%	169B
MEDTRONIC PLC	-0.07%	-2.55%	-11.59%	+12.86%	110B
STRYKER CORPORATION	+0.90%	+1.13%	-25.66%	+3.60%	106B
ESSILORLUXOTTICA	-1.24%	-0.76%	-49.50%	-12.08%	73.87B
CENCORA, INC.	-0.24%	+0.69%	+2.08%	+71.44%	58.98B
HOYA CORPORATION	-0.86%	+2.96%	+12.91%	+61.58%	51.28B
BECTON, DICKINSON AND COMPANY	-0.71%	-3.82%	-8.68%	-31.71%	48.16B
IDEXX LABORATORIES, INC.	+0.12%	-0.17%	-17.87%	+21.91%	40.84B
DEXCOM, INC.	-1.01%	-1.45%	+27.31%	-6.14%	32.21B
Average	-0.23%	-0.86%	-10.95%	+13.69%	76.69B
Weighted average by Cap.	+0.03%	-1.30%	-17.07%	+11.23%

	2026 *	2027 *
Net sales	13.2M 14.86M 12.32M 11.23M 21.18M 1.43B 21.38M 149M 57.77M 730M 55.78M 54.57M 2.34B	14.5M 16.32M 13.53M 12.34M 23.26M 1.57B 23.48M 164M 63.46M 802M 61.27M 59.94M 2.57B
Net income	-2.5M -2.81M -2.33M -2.13M -4.01M -270M -4.05M -28.24M -10.94M -138M -10.56M -10.33M -444M	-2.5M -2.81M -2.33M -2.13M -4.01M -270M -4.05M -28.24M -10.94M -138M -10.56M -10.33M -444M
Net Debt	2.6M 2.93M 2.43M 2.21M 4.17M 281M 4.21M 29.37M 11.38M 144M 10.99M 10.75M 462M	7.4M 8.33M 6.91M 6.3M 11.87M 801M 11.98M 83.58M 32.39M 409M 31.27M 30.59M 1.31B